Financial Data and Key Metrics Changes - Unilever reported a 4% underlying sales growth in Q3 2025, with a volume growth acceleration to 1.7% excluding ice cream, despite subdued markets [2][4] - The underlying sales growth was 3.9% with underlying price growth at 2.4% and volume contributing 1.5% [7][8] - Turnover for Q3 was EUR 14.7 billion, down 3.5% year on year, with a negative currency impact of 6.1% [27][28] Business Line Data and Key Metrics Changes - Beauty and Well-being saw a 5.1% underlying sales growth, driven by strong volume growth [15] - Personal Care achieved a 4.1% underlying sales growth, with volume growth of 1% and price growth of 3.1% [17] - Home Care underlying sales grew 3.1%, with volume growth of 2.5% and price growth of 0.6% [20] Market Data and Key Metrics Changes - North America grew underlying sales by 5.5%, with volume growth of 5.4%, driven by Personal Care and Well-being brands [9][10] - Europe experienced a 1.1% underlying sales growth, with a 0.6% decline in volume and 1.7% growth from price [10][11] - Emerging markets grew by 4.1%, led by a return to growth in Indonesia and China [4][12] Company Strategy and Development Direction - The company is focusing on premium segments and fast-growing channels, with a significant shift towards digital commerce [2][32] - Unilever is preparing for the demerger of its ice cream business, expected to be completed in 2025 [5][26] - The strategic priority is to strengthen the portfolio with more beauty, well-being, and personal care products [32][34] Management's Comments on Operating Environment and Future Outlook - Management remains confident in achieving full-year outlook despite some softness in certain markets, particularly Latin America [30][31] - The company expects underlying sales growth to remain within the 3% to 5% multiyear range, with volume growth in Q4 expected to be at least in line with Q3 [30][31] - Management highlighted the importance of premium innovations and brand investments to drive future growth [34][36] Other Important Information - The company is experiencing a significant shift in consumer behavior towards premium products and digital channels [32][34] - The macroeconomic environment in India is favorable, with recent tax reforms expected to boost consumption [12][14] - The company is committed to maintaining competitive pricing while managing inflationary pressures [57][58] Q&A Session Summary Question: Clarification on volume growth expectations into 2026 - Management confirmed a 2% volume growth expectation into 2026, reflecting confidence in long-term market performance [37][50] Question: Growth of well-being and prestige brands in North America - Management reported strong double-digit growth in well-being brands like Liquid IV and Nutrafol, with a recovery in prestige beauty brands [41][42] Question: Actions taken in Latin America due to macroeconomic pressures - Management acknowledged challenges in Brazil and highlighted corrective actions taken in pricing and product formats to regain competitiveness [45][49] Question: Pricing outlook in a benign commodity cost environment - Management indicated that while commodity costs are benign, pricing adjustments will be necessary to manage inflationary pressures [53][58] Question: Performance of hair care brands in the U.S. - Management noted that TRESemmé has returned to growth in Q3, while some brands were consciously delisted to focus on sustainable growth [64][66] Question: Update on Liquid IV's global rollout - Management confirmed that Liquid IV is performing well in the U.S. and has been rolled out to eight markets, with plans for further expansion [66][67] Question: Performance in Mexico and expectations for hard currency earnings - Management reported soft market conditions in Mexico but expressed confidence in achieving positive hard currency earnings for the year [92][96] Question: Performance in Indonesia and China - Management expressed satisfaction with the growth in Indonesia and noted improvements in China, with all business groups returning to growth [99][101]

Core Insights - Nature's Sunshine Products, Inc. has appointed Kenneth Romanzi as the new CEO, effective October 29, 2025, succeeding Terrence Moorehead [1][3] Company Overview - Nature's Sunshine is a leading manufacturer of high-quality herbal and nutritional supplements, operating in over 40 countries and focusing on natural health and wellness [8] - The company manufactures most of its products in state-of-the-art facilities to ensure high quality, safety, and efficacy [8] Leadership Experience - Kenneth Romanzi has over 40 years of experience in the consumer packaged goods (CPG) industry, including significant roles at B&G Foods, Nabisco, and Ocean Spray [4][5] - At B&G Foods, he expanded revenue from $1.6 billion to $2 billion and improved profitability while reducing leverage [2][4] - Romanzi has held various leadership positions, including President and CEO of The Ultimate Juice Company and President of the U.S. toys division at Hasbro [5] Strategic Vision - The Board of Directors believes Romanzi's transformational leadership will accelerate the company's digital empowerment and omnichannel offerings [3] - Romanzi expressed commitment to driving sustainable, long-term profitability and shareholder value while enhancing the company's global brand promise [3]

Core Viewpoint - Sunflower Bank, N.A. has reduced its stake in Procter & Gamble by selling 106,032 shares for approximately $16.56 million during Q3 2025, leaving it with a minimal holding of 3,777 shares valued at $580,336 as of September 30, 2025 [2][3]. Company Overview - Procter & Gamble is a global leader in consumer packaged goods, with a diverse product lineup and extensive distribution network [4]. - The company generates revenue primarily through the sale of consumer packaged goods, targeting a broad base of global consumers [6]. Financial Performance - Procter & Gamble reported a revenue of $84.28 billion and a net income of $16.07 billion for the trailing twelve months (TTM) [3]. - The company's dividend yield is currently at 2.74%, which is the highest level since late 2022 [9]. Stock Performance - As of October 9, 2025, Procter & Gamble's stock price was $150.58, reflecting an 11.0% decline over the past year, underperforming the S&P 500 by 25.3 percentage points [3][11]. Strategic Initiatives - The company is undergoing a restructuring aimed at streamlining operations and boosting profits, which could positively impact stock performance if executed well [10]. - Procter & Gamble has announced a collaboration with Universal Pictures to introduce movie-themed scents, which may enhance brand visibility and consumer engagement [10].

Core Insights - BellRing Brands has extended its partnership with Numerator, emphasizing the importance of consumer panel data in enhancing visibility and insights for strategic decision-making [1][2][3] Company Overview - Numerator is a data and tech company that integrates first-party data from over 1 million US households with advanced technology to provide comprehensive consumer insights for the market research industry [4] - The company has a workforce of 5,400 employees globally and serves 80 of the top 100 CPG brands [4] Industry Trends - The health and wellness category is rapidly evolving, with protein becoming a significant focus for consumers [2] - There is a growing demand for convenience, value, and innovation in protein-based nutrition, influenced by the rise of GLP-1 medications [3] Strategic Focus - BellRing Brands aims to expand household penetration of ready-to-drink (RTD) shakes and strengthen its leadership position in the protein market [3] - The partnership with Numerator provides BellRing Brands with deep consumer insights to tailor products effectively and position the brand for sustained growth [3]

Core Insights - Women We Admire has announced The Top 50 Chief Creative Officers of 2025, highlighting the importance of Chief Creative Officers in shaping brand identity and long-term strategy for organizations [1] - The honorees represent a diverse range of creative leadership, reflecting the evolving landscape of the industry [1] Group 1: Notable Honorees - Tuesday Poliak, Chief Creative Officer at RP3 Agency, has over two decades of experience and has led award-winning campaigns for major brands like Verizon Wireless and Pfizer [2] - Rosie Bardales, Chief Creative Officer of VML, oversees significant accounts such as Coca-Cola and Unilever, while also mentoring young creative talent [3] - Price Latimer, Chief Creative Officer and Co-Founder of Alkemis Paint, has 25 years of experience in various creative fields, focusing on wellness and sustainability [4] Group 2: Additional Honorees - The list includes other notable figures such as Lora Lukin (Publicis Groupe), Cathy Dean (Levi Strauss & Co.), and Renata Maia (Ogilvy), among others [6] - The full list of honorees can be accessed through the Women We Admire website [7]

Core Insights - The Procter & Gamble Company (NYSE:PG) is highlighted as a top blue-chip stock to consider at its 52-week lows, with upcoming fiscal first-quarter results set to be released on October 24, 2023 [1] Financial Performance - In the fiscal fourth quarter of 2024, the company reported a revenue of $20.89 billion, reflecting a year-over-year growth of 1.74% and exceeding consensus estimates by $46.86 million. The earnings per share (EPS) was $1.48, surpassing estimates by $0.06. Management anticipates full-year revenue growth for 2026 to be between 1% to 5% [2] Analyst Ratings - Wall Street analysts are optimistic about The Procter & Gamble Company, with Filippo Falorni from Citi reiterating a Buy rating and a price target of $181 on September 16. Christopher Carey from Wells Fargo also maintained a Buy rating but adjusted the price target from $173 to $170 on September 25 [3] Company Overview - The Procter & Gamble Company is engaged in the production and sale of branded consumer packaged goods on a global scale, with product categories including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby & Family Care [4]

Group 1 - The Procter & Gamble Company (NYSE:PG) is recognized as one of the 11 Most Profitable Blue Chip Stocks to consider for investment [1] - Wells Fargo has revised its price target for Procter & Gamble from $173 to $170, reflecting a 1.73% decrease, while maintaining an Overweight rating [2] - Analysts show consistent confidence in Procter & Gamble's long-term growth, with BNP Paribas reiterating an Outperform rating at $177 and UBS lowering its target to $180 [2] Group 2 - Procter & Gamble has a diverse portfolio across various categories, generating approximately $85 billion in annual sales, with over 20 brands each exceeding $1 billion in international sales [3] - The company's stock stability is attributed to a balanced mix of high-growth and mature product areas, alongside ongoing global demand for consumer necessities [3][4] - Procter & Gamble offers branded consumer packaged goods in sectors such as Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care [4]

Core Insights - Clorox Company (CLX) is effectively managing margins through holistic strategies, product innovations, and the IGNITE strategy, capitalizing on pricing strength to support growth and mitigate cost pressures [1][10] - The company is proactively adjusting its pricing strategy to address inflation and changing consumer behaviors, with a focus on premium pricing for core brands [2] - Clorox has implemented a dual pricing strategy using advanced analytics to balance affordability for consumers with sustained profitability, which has reinforced gross margin expansion despite soft volume trends [3][10] Financial Performance - Clorox delivered flat gross margin in Q4 fiscal 2025 after ten consecutive quarters of expansion, demonstrating a disciplined pricing approach and cost-saving initiatives that have bolstered margins [4] - All three core business units of Clorox posted solid year-over-year growth in Q4 fiscal 2025, indicating broad-based segment strength [4][10] - The Zacks Consensus Estimate for CLX's fiscal 2026 earnings implies a year-over-year decline of 21.5%, while fiscal 2027 shows an anticipated growth of 14.1% [11] Valuation Metrics - Clorox shares have declined by 24.7% year-to-date, compared to an industry decline of 8.1% [7] - The company trades at a forward price-to-earnings ratio of 19.73X, slightly above the industry average of 19.12X [8]

Core Viewpoint - Procter & Gamble (P&G) is undergoing significant restructuring, including cutting 7,000 jobs by mid-2027, to address slowing sales and enhance productivity, with a focus on non-manufacturing roles and potential brand divestitures [2][7][5]. Group 1: Job Cuts and Restructuring - P&G plans to cut 7,000 jobs, representing 6.4% of its global workforce of 109,000 employees, primarily targeting non-manufacturing roles [2][5]. - The company aims to reduce jobs outside of its 99 factories worldwide by 15% as part of its restructuring efforts [2]. - The last major restructuring in 2012 involved cutting 5,700 workers, or over 4% of 129,000 employees at that time [8]. Group 2: Sales Performance and Market Strategy - P&G's organic sales growth has been stagnant, with only 1% to 2% growth per quarter since spring 2024, attributed to consumer spending cuts amid inflation and trade tensions [3][4]. - The company is reviewing its markets and product offerings, considering exiting underperforming categories and brands, particularly in international markets [20][21]. - P&G's core markets, including the U.S., China, Japan, Canada, and Western Europe, saw organic sales growth of 2%, while other markets lagged at 1% [20]. Group 3: Leadership Changes - A leadership transition is underway with Shailesh Jejurikar set to become the new CEO in January, which may lead to further executive departures [26][27]. - The restructuring is described as "surgical," focusing on rationalizing product and geographic mixes to enhance operational focus [23]. Group 4: Historical Context and Future Outlook - P&G has a history of significant job cuts and brand divestitures, having cut 37,000 jobs from buyouts and divestitures between 2011 and 2018 [13][12]. - The company is considering selling off brands, although specific details on which brands may be affected remain unclear [18][22].

Core Insights - The current tariff environment has significantly impacted corporate financial results and finance departments' planning and forecasting capabilities across various industries [1] Group 1: Impact on Profitability and Forecasting - A survey of 942 finance leaders revealed that 59% reported a moderate impact on profitability due to tariffs, while 64% indicated that tariffs affected their ability to prepare timely and reliable forecasts [2] - In the United States, 76% of respondents reported at least a moderate impact on forecasting, compared to 60% in Europe and 46% in Asia-Pacific [3] Group 2: Industry-Specific Effects - Financial services, consumer packaged goods, and retail sectors reported the highest levels of impact on profitability, with 70% of U.S.-based companies experiencing at least a moderate impact [4] - Manufacturing and distribution organizations are identified as the most affected industries regarding tariff-related forecasting issues [3] Group 3: Supply Chain Adjustments - Companies are addressing supply chain concerns by enhancing communication with suppliers (60%) and increasing third-party risk management oversight (52%) [4] - A significant portion of companies are sourcing materials locally (39%) and diversifying their supply chains across multiple regions (35%), while 51% have made no changes to their outsourcing or offshoring strategies [5] Group 4: Role of CFOs - CFOs are positioned to act as the "voice of reason" in discussions with shareholders and board members regarding the impact of tariffs on costs and profit margins [5] - Strong cross-functional collaboration is necessary for addressing questions related to tariffs, including cost of goods sold and pricing adjustments [6]